These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23087055)

  • 1. Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).
    Malofeeva EV; Domanitskaya N; Gudima M; Hopper-Borge EA
    Cancer Res; 2012 Dec; 72(24):6457-67. PubMed ID: 23087055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.
    Chen DQ; Xie Y; Cao LQ; Fleishman JS; Chen Y; Wu T; Yang DH
    Drug Resist Updat; 2024 Mar; 73():101062. PubMed ID: 38330827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
    Zhou Y; Hopper-Borge E; Shen T; Huang XC; Shi Z; Kuang YH; Furukawa T; Akiyama S; Peng XX; Ashby CR; Chen X; Kruh GD; Chen ZS
    Biochem Pharmacol; 2009 Mar; 77(6):993-1001. PubMed ID: 19150344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
    Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD
    Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.
    Kathawala RJ; Wang YJ; Ashby CR; Chen ZS
    Chin J Cancer; 2014 May; 33(5):223-30. PubMed ID: 24103790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of anticancer drug sensitivity in multidrug resistance cells overexpressing ATP-binding cassette (ABC) transporter ABCC10 by CP55, a synthetic derivative of 5-cyano-6-phenylpyrimidin.
    Wang JQ; Wang B; Ma LY; Shi Z; Liu HM; Liu Z; Chen ZS
    Exp Cell Res; 2021 Aug; 405(2):112728. PubMed ID: 34246653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
    Chen ZS; Hopper-Borge E; Belinsky MG; Shchaveleva I; Kotova E; Kruh GD
    Mol Pharmacol; 2003 Feb; 63(2):351-8. PubMed ID: 12527806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
    Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
    PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump.
    Teijaro CN; Munagala S; Zhao S; Sirasani G; Kokkonda P; Malofeeva EV; Hopper-Borge E; Andrade RB
    J Med Chem; 2014 Dec; 57(24):10383-90. PubMed ID: 25419978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response.
    Domanitskaya N; Wangari-Talbot J; Jacobs J; Peiffer E; Mahdaviyeh Y; Paulose C; Malofeeva E; Foster K; Cai KQ; Zhou Y; Egleston B; Hopper-Borge E
    Br J Cancer; 2014 Aug; 111(4):696-707. PubMed ID: 24937672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.
    Hopper-Borge E; Xu X; Shen T; Shi Z; Chen ZS; Kruh GD
    Cancer Res; 2009 Jan; 69(1):178-84. PubMed ID: 19118001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
    Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
    Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.
    Sauna ZE; Nandigama K; Ambudkar SV
    J Biol Chem; 2004 Nov; 279(47):48855-64. PubMed ID: 15364914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).
    Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS
    Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
    Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
    Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high turnover Drosophila multidrug resistance-associated protein shares the biochemical features of its human orthologues.
    Szeri F; Iliás A; Pomozi V; Robinow S; Bakos E; Váradi A
    Biochim Biophys Acta; 2009 Feb; 1788(2):402-9. PubMed ID: 19059376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
    Kathawala RJ; Wei L; Anreddy N; Chen K; Patel A; Alqahtani S; Zhang YK; Wang YJ; Sodani K; Kaddoumi A; Ashby CR; Chen ZS
    Oncotarget; 2015 Jan; 6(1):510-21. PubMed ID: 25402202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.
    Kuang YH; Shen T; Chen X; Sodani K; Hopper-Borge E; Tiwari AK; Lee JW; Fu LW; Chen ZS
    Biochem Pharmacol; 2010 Jan; 79(2):154-61. PubMed ID: 19720054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
    Leslie EM; Mao Q; Oleschuk CJ; Deeley RG; Cole SP
    Mol Pharmacol; 2001 May; 59(5):1171-80. PubMed ID: 11306701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.
    Kathawala RJ; Sodani K; Chen K; Patel A; Abuznait AH; Anreddy N; Sun YL; Kaddoumi A; Ashby CR; Chen ZS
    Mol Cancer Ther; 2014 Mar; 13(3):714-23. PubMed ID: 24431074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.